Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.

Source:http://linkedlifedata.com/resource/pubmed/id/17047649

Br. J. Cancer 2006 Oct 23 95 8 1005-12

Download in:

View as

Triples

General Info

PMID
17047649